<!DOCTYPE html>
<html>
<head>

      <meta http-equiv="Content-Type" content="text/html; charset=utf-8">

        <script> var url = encodeURIComponent('https://www.science.org/content/webinar/opportunities-and-challenges-blood-based-biomarkers-alzheimer-s-disease');</script>

        <script> var body_html = '<body > <div > <div > <div> <div > <div > <div > <div > <div > <div > <div > <span >Advertisement</span> </div> </div> </div> </div> </div> </div> </div> <header > <div ><div ><div ><div ><div ><div ><div ><a ><div >science</div></a></div></div><div ><div ><a ><div >science advances</div></a></div></div><div ><div ><a ><div >science immunology</div></a></div></div><div ><div ><a ><div >science robotics</div></a></div></div><div ><div ><a ><div >science signaling</div></a></div></div><div ><div ><a ><div >science translational medicine</div></a></div></div><div ><div ><a ><div >science partner journals</div></a></div></div></div></div></div></div></div> <div > <div > <div > <div > <div ><div ><div ><label >Searching:</label><div ><div ><div >AnywhereScienceScience AdvancesScience ImmunologyScience RoboticsScience SignalingScience Translational Medicine</div></div></div></div><div > <a ><u>Advanced Search</u></a> </div></div></div> </div> </div> </div> <div > <div > <div > <h6 >Trending Terms:</h6> <ul > <li > covid-19 </li> <li > climate </li> <li > science policy </li> <li > genome editing </li> <li > batteries </li> </ul> </div> </div> </div> </div> </header><div ><div ><div > <div > <div > <ul > <li > Custom Publishing </li> <li > Advertising Kits </li> <li > Custom Publishing Info </li> <li > Webinars </li> </ul> </div> </div> GET OUR E-ALERTS </div></div></div> <main > <section> <div > <div > <div > <div >  <div > <ul > <li >webinar</li><li >Technology</li><li >Sponsored by MilliporeSigma </li> </ul> <div ><h1 >Opportunities and challenges of blood-based biomarkers in Alzheimer's disease</h1></div> <ul ><li >15 Dec 2021</li><li >12:00 PM ET</li><li >Speakers:Lei Liu, M.D., Ph.D,Anitaben Tailor, Ph.D.</li><li >Moderator:Jackie Oberst, Ph.D.</li> </ul> </div> </div> </div> </div> </div> </section> <div > <div > <div > <div > <div > <article > <section> <div > <div > <div > <div > <time > <div >15</div> <div > <div >Dec</div> <div >2021</div> </div> </time> <time > <div >12:00</div> <div > <div >PM</div> <div >ET</div> </div> </time> <div > Register NOWRemaining time: </div> </div> </div> </div> </div> <div > <div >Lei Liu, M.D., Ph.DSpeaker</div> <div >Anitaben Tailor, Ph.D.Speaker</div> <div >Jackie Oberst, Ph.D.Moderator</div> </div> <div > <div > <div > <span >This webinar is brought to you by the <a ><cite>Science</cite>/AAAS Custom Publishing Office</a>.</span> </div> </div> <p>Identifying more sensitive biomarker tests for Alzheimer’s disease (AD) is an unmet medical need. It is key in the global efforts to validate disease-modifying AD therapeutics and identify appropriate recipients in clinical trials once more therapies are approved. Fluid biomarkers, especially plasma-based biomarkers, become the most attractive ones as they are non-invasive, relatively economical, and easy to obtain. Emerging blood biomarkers, including amyloid β monomers, oligomers, tau/p-tau, neurofilament light chain, and inflammatory factors, are gathering tremendous research interest. However, there are also challenges in developing blood biomarkers for neurological disease with specificity, precision, and reproducibility. First, biologically, there could be a tiny amount of proteins of the central nervous system entering into the peripheral bloodstream. Second, biochemically, the enriched and complex matrix of human blood strongly interferes with the detection system we use for protein identification and quantification. Third, technically, it is critical to establish a system with high reliability that is also capable of high throughput. Our expert speakers will discuss strategies in developing an ultrasensitive immunoassay* to precisely measure oligomeric amyloid β in human plasma.During the webinar, the viewers will:</p> <ul> <ul> <li>Obtain insights into blood-based biomarkers used in neurological diseases such as Alzheimer’s disease</li> <li>Discover the challenges and opportunities behind creating blood-based biomarker immunoassays</li> <li>Be able to ask questions during the live broadcast.</li> </ul> </ul> <p>This webinar will last for approximately 60 minutes.</p> <p>*For Research Use Only. Not For Use In Diagnostic Procedures.</p> </div> </section> </article> </div> <div > <div > <h2 >SPEAKER BIOS</h2> <div > <div > <div > <h4>Lei Liu, M.D., Ph.D</h4> </div> <div > <div > <p>Harvard Medical SchoolBoston, MA</p> </div> <p>Lei Liu, M.D., Ph.D., studied the neurochemistry of Alzheimer’s disease (AD) at the Shiga University of Medical Science (Otsu, Japan) and completed his Ph.D. thesis in the lab of Dr. Masaki Nishimura. During his graduate research, which involved the characterization of a novel endogenous regulator of the AD-relevant γ-secretase complex, Lei was awarded the best basic research of the year in 2014 by the Japan Society for Dementia Research and the Takeda Medical Research Award in 2015 for his work on γ-secretase. Following his research interest in dementia, he joined the lab of Dr. Dennis Selkoe at Harvard Medical School/Brigham and Women’s Hospital in late 2016, where he currently works as an Assistant Professor of Neurology at Harvard Medical School. He has published many significant peer-reviewed research articles on the enzymology involved in AD pathogenesis in prestigious journals, such as Journal of Cell Biology, Nature Communications, Alzheimer’s Dementia, Neuron, and Journal of Biological Chemistry.</p> <p>In addition to basic molecular biology research, he is also an expert in antibody biology and immunoassay development. His ongoing work on plasma biomarkers in AD is built on multiple ultrasensitive and unique assays to detect up to fg/mL AD-relevant proteins in as little as 10 µL of human plasma. His recent development, an immunoassay to sensitively and specifically quantify the oligomeric state of amyloid-β (oAβ), is the first method that has been thoroughly validated for human plasma to monitor Aβ dynamics in the peripheral blood. This could serve as a critical tool to monitor AD stages and therapeutic interventions. His research goal is to bridge basic research to clinical applications and bring real-life impacts on patient treatments and quality of life.</p> </div> </div> </div> <div > <div > <div > <h4>Anitaben Tailor, Ph.D.</h4> </div> <div > <div > <p>MilliporeSigmaBurlington, MA</p> </div> <p>Dr. Tailor has over 10 years of immunoassay platform experience in the biopharmaceutical industry. Anita earned her Master’s in Pharmacology at Kings College, London, and then went on to do her Ph.D. in Biochemical Immunopharmacology at the University of London, UK. She was a postdoctoral fellow in physiology and pharmacology at LSU Health Sciences, followed by faculty positions at Johns Hopkins and the U.S. National Institutes of Health. In 2009, Anita moved into industry as a Field Application Scientist for Meso Scale Diagnostics and Singulex (MilliporeSigma). Then in 2016, Anita was appointed the global role of SMC™ Technology and Application Lead within the Life Science Division at MilliporeSigma, where she led multiple teams globally on the utility of SMC™ technology as a bioanalytical tool for multiple research applications within industry and academia. More recently, Anita joined the global Biology Technical Marketing group, focusing on the immunoassay portfolio within pharma and contract research organizations.</p> </div> </div> </div> <h2 >MODERATOR BIO</h2> <div > <div > <div > <h4>Jackie Oberst, Ph.D.</h4> </div> <div > <div > <p>Science/AAASWashington, DC</p> </div> <p>Dr. Oberst did her undergraduate training at the University of Maryland, College Park, and her Ph.D. in Tumor Biology at Georgetown University, Washington D.C. She combined her interests in science and writing by pursuing an M.A. in Journalism from the Philip Merrill College of Journalism at the University of Maryland, College Park. Dr. Oberst joined Science/AAAS in 2016 as the Assistant Editor for Custom Publishing. Before then she worked at Nature magazine, the Howard Hughes Medical Institute, The Endocrine Society, and the National Institutes of Mental Health.</p> </div> </div> </div> </div> <div > <h5 >Sponsored By:</h5> </div> </div> </div> </div> </div> </div> <div > <div > <div > <div > <div > <h2 >Webinars</h2> <div ><div ><div > <article > <div > <div > <div > <div >Technology<time >15 Dec 2021</time> Sponsored by MilliporeSigma </div> <div > <h3 >Opportunities and challenges of blood-based biomarkers in Alzheimer's disease</h3> </div> <div ><p>Identifying more sensitive biomarker tests for Alzheimer’s disease (AD) is an unmet medical need. It is key in the global efforts to validate disease-modifying AD therapeutics and identify appropriate recipients in clinical trials once more therapies are approved. Fluid biomarkers, especially plasma-based biomarkers, become the most attractive ones as they are non-invasive, relatively economical, and easy to obtain. Emerging blood biomarkers, including amyloid β monomers, oligomers, tau/p-tau, neurofilament light chain, and inflammatory factors, are gathering tremendous research interest. However, there are also challenges in developing blood biomarkers for neurological disease with specificity, precision, and reproducibility. First, biologically, there could be a tiny amount of proteins of the central nervous system entering into the peripheral bloodstream. Second, biochemically, the enriched and complex matrix of human blood strongly interferes with the detection system we use for protein identification and quantification. Third, technically, it is critical to establish a system with high reliability that is also capable of high throughput. Our expert speakers will discuss strategies in developing an ultrasensitive immunoassay* to precisely measure oligomeric amyloid β in human plasma.During the webinar, the viewers will:</p> <ul> <ul> <li>Obtain insights into blood-based biomarkers used in neurological diseases such as Alzheimer’s disease</li> <li>Discover the challenges and opportunities behind creating blood-based biomarker immunoassays</li> <li>Be able to ask questions during the live broadcast.</li> </ul> </ul> <p>This webinar will last for approximately 60 minutes.</p> <p>*For Research Use Only. Not For Use In Diagnostic Procedures.</p></div> </div> <div > <div > <div >15</div> <div > <div >Dec</div> <div >2021</div> </div> </div> Register Now </div> </div> </div> </article> </div><div > <article > <div > <div > <div > <div >Technology<time >8 Dec 2021</time> Sponsored by Tecan </div> <div > <h3 >Enabling the transition between research and clinical medicine in oncology</h3> </div> <div ><p>The translation of bench research into the clinical environment has accelerated significantly in recent years, and the need for clinically validated workflows has never been stronger. This webinar takes a closer look at this need, particularly in the oncology space, and discusses what the future for workflow validation might be. The considerable knowledge built up over years—and especially during the recent COVID-19 pandemic—is relevant to many disease states and can be applied universally, ensuring that globally standardized, scalable technologies can realize their full clinical potential.The discussion will include:</p> <ul> <li>The latest developments in integrated diagnostics and patient profiling, combining molecular and proteomics workflows</li> <li>The urgent need for translational research of biomarkers that have clinical relevance for optimizing diagnosis and treatment plans</li> <li>The challenges of translating new techniques—such as liquid biopsies—into regulated, scalable methodologies that will drive future global diagnostics and therapeutics</li> <li>The importance of building firm foundations in robust and reproducible research technologies, democratization of automated workflows, and digital connectivity of data. </li> </ul> <p>This webinar will last for approximately 60 minutes.</p></div> </div> </div> </div> </article> <article > <div > <div > <div > <div >Technology<time >30 Nov 2021</time> Sponsored by Illumina </div> <div > <h3 >Redefining NGS in Cancer Research</h3> </div> <div ><p>Cancer research using next-generation sequencing (NGS) has ushered in numerous advancements in diagnosis and treatment. In addition to identifying individual targetable alterations, sequencing methods can now reveal tumor mutational load and tumor-specific antigens that might predict a therapeutic response to targeted therapies, immune-checkpoint inhibitors, and personalized anticancer vaccines. Emerging clinical applications of cancer genomics include monitoring treatment responses and characterizing mechanisms of resistance. Genomic assays that enable characterization of somatic and germline defects in individual tumor samples are increasingly being used in clinical diagnostics as a means of identifying therapeutic options. Additionally, the occurrence of shared targetable alterations across diverse tumor types has prompted new paradigms in the application of genomic profiling and the design of clinical trials.Although often perceived as a primarily genomic and/or transcriptomic analysis approach, NGS has evolved beyond the genome and transcriptome. It can now be used to characterize the proteome, epigenome, noncoding RNAs, and even small RNAs. Furthermore, cellular characterization can occur at multiple levels of resolution. If someone is seeking to characterize average state of many cells, bulk sequencing is still a fantastic, straightforward application. However, it’s also now possible to embrace the inherent heterogeneity of a tissue by performing single-cell sequencing and understanding individual cells (but without spatial context). These applications further enrich cancer research and drive future breakthroughs.During this webinar, our expert speakers will:</p> <ul> <li>Provide background information on NGS</li> <li>Discuss the achievements and challenges associated with NGS</li> <li>Discuss how an integrated multiomics approach can be used in cancer diagnosis and treatment</li> <li><span>Answer your questions during the live broadcast.</span></li> </ul></div> </div> </div> </div> </article> </div></div></div> </div> </div> </div> </div> </div> <div > <renderdropzone ></renderdropzone> </div> </main> </div> </div> </div> </body>'</script>

      </head>
        <body class="valid" valid="valid" title="valid: True, node: 1, tag: body, level: 1" node_number="1"> <div class="valid" valid="valid" title="valid: True, node: 2, tag: div, level: 2" node_number="2"> <div class="valid" valid="valid" title="valid: True, node: 3, tag: div, level: 3" node_number="3"> <div class="valid" valid="valid" title="valid: True, node: 4, tag: div, level: 4" node_number="4"> <div class="valid" valid="valid" title="valid: True, node: 5, tag: div, level: 5" node_number="5"> <div class="valid" valid="valid" title="valid: True, node: 6, tag: div, level: 6" node_number="6"> <div class="valid" valid="valid" title="valid: True, node: 7, tag: div, level: 7" node_number="7"> <div class="valid" valid="valid" title="valid: True, node: 8, tag: div, level: 8" node_number="8"> <div class="valid" valid="valid" title="valid: True, node: 9, tag: div, level: 9" node_number="9"> <div class="valid" valid="valid" title="valid: True, node: 10, tag: div, level: 10" node_number="10"> <div class="valid" valid="valid" title="valid: True, node: 11, tag: div, level: 11" node_number="11"> <span class="valid" valid="valid" title="valid: True, node: 12, tag: span, level: 12" node_number="12">Advertisement</span> </div> </div> </div> </div> </div> </div> </div> <header class="valid" valid="valid" title="valid: True, node: 13, tag: header, level: 5" node_number="13"> <div class="valid" valid="valid" title="valid: True, node: 14, tag: div, level: 6" node_number="14"><div class="valid" valid="valid" title="valid: True, node: 15, tag: div, level: 7" node_number="15"><div class="valid" valid="valid" title="valid: True, node: 16, tag: div, level: 8" node_number="16"><div class="valid" valid="valid" title="valid: True, node: 17, tag: div, level: 9" node_number="17"><div class="valid" valid="valid" title="valid: True, node: 18, tag: div, level: 10" node_number="18"><div class="valid" valid="valid" title="valid: True, node: 19, tag: div, level: 11" node_number="19"><div class="valid" valid="valid" title="valid: True, node: 20, tag: div, level: 12" node_number="20"><a class="valid" valid="valid" title="valid: True, node: 21, tag: a, level: 13" node_number="21"><div class="valid" valid="valid" title="valid: True, node: 22, tag: div, level: 14" node_number="22">science</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 23, tag: div, level: 11" node_number="23"><div class="valid" valid="valid" title="valid: True, node: 24, tag: div, level: 12" node_number="24"><a class="valid" valid="valid" title="valid: True, node: 25, tag: a, level: 13" node_number="25"><div class="valid" valid="valid" title="valid: True, node: 26, tag: div, level: 14" node_number="26">science advances</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 27, tag: div, level: 11" node_number="27"><div class="valid" valid="valid" title="valid: True, node: 28, tag: div, level: 12" node_number="28"><a class="valid" valid="valid" title="valid: True, node: 29, tag: a, level: 13" node_number="29"><div class="valid" valid="valid" title="valid: True, node: 30, tag: div, level: 14" node_number="30">science immunology</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 31, tag: div, level: 11" node_number="31"><div class="valid" valid="valid" title="valid: True, node: 32, tag: div, level: 12" node_number="32"><a class="valid" valid="valid" title="valid: True, node: 33, tag: a, level: 13" node_number="33"><div class="valid" valid="valid" title="valid: True, node: 34, tag: div, level: 14" node_number="34">science robotics</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 35, tag: div, level: 11" node_number="35"><div class="valid" valid="valid" title="valid: True, node: 36, tag: div, level: 12" node_number="36"><a class="valid" valid="valid" title="valid: True, node: 37, tag: a, level: 13" node_number="37"><div class="valid" valid="valid" title="valid: True, node: 38, tag: div, level: 14" node_number="38">science signaling</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 39, tag: div, level: 11" node_number="39"><div class="valid" valid="valid" title="valid: True, node: 40, tag: div, level: 12" node_number="40"><a class="valid" valid="valid" title="valid: True, node: 41, tag: a, level: 13" node_number="41"><div class="valid" valid="valid" title="valid: True, node: 42, tag: div, level: 14" node_number="42">science translational medicine</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 43, tag: div, level: 11" node_number="43"><div class="valid" valid="valid" title="valid: True, node: 44, tag: div, level: 12" node_number="44"><a class="valid" valid="valid" title="valid: True, node: 45, tag: a, level: 13" node_number="45"><div class="valid" valid="valid" title="valid: True, node: 46, tag: div, level: 14" node_number="46">science partner journals</div></a></div></div></div></div></div></div></div> <div class="valid" valid="valid" title="valid: True, node: 47, tag: div, level: 6" node_number="47"> <div class="valid" valid="valid" title="valid: True, node: 48, tag: div, level: 7" node_number="48"> <div class="valid" valid="valid" title="valid: True, node: 49, tag: div, level: 8" node_number="49"> <div class="valid" valid="valid" title="valid: True, node: 50, tag: div, level: 9" node_number="50"> <div class="valid" valid="valid" title="valid: True, node: 51, tag: div, level: 10" node_number="51"><div class="valid" valid="valid" title="valid: True, node: 52, tag: div, level: 11" node_number="52"><div class="valid" valid="valid" title="valid: True, node: 53, tag: div, level: 12" node_number="53"><label class="valid" valid="valid" title="valid: True, node: 54, tag: label, level: 13" node_number="54">Searching:</label><div class="valid" valid="valid" title="valid: True, node: 55, tag: div, level: 13" node_number="55"><div class="valid" valid="valid" title="valid: True, node: 56, tag: div, level: 14" node_number="56"><div title="valid: False, node: 57, tag: div, level: 15" node_number="57">AnywhereScienceScience AdvancesScience ImmunologyScience RoboticsScience SignalingScience Translational Medicine</div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 58, tag: div, level: 12" node_number="58"> <a class="valid" valid="valid" title="valid: True, node: 59, tag: a, level: 13" node_number="59"><u class="valid" valid="valid" title="valid: True, node: 60, tag: u, level: 14" node_number="60">Advanced Search</u></a> </div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 61, tag: div, level: 7" node_number="61"> <div class="valid" valid="valid" title="valid: True, node: 62, tag: div, level: 8" node_number="62"> <div class="valid" valid="valid" title="valid: True, node: 63, tag: div, level: 9" node_number="63"> <h6 class="valid" valid="valid" title="valid: True, node: 64, tag: h6, level: 10" node_number="64">Trending Terms:</h6> <ul class="valid" valid="valid" title="valid: True, node: 65, tag: ul, level: 10" node_number="65"> <li class="valid" valid="valid" title="valid: True, node: 66, tag: li, level: 11" node_number="66"> covid-19 </li> <li class="valid" valid="valid" title="valid: True, node: 67, tag: li, level: 11" node_number="67"> climate </li> <li class="valid" valid="valid" title="valid: True, node: 68, tag: li, level: 11" node_number="68"> science policy </li> <li class="valid" valid="valid" title="valid: True, node: 69, tag: li, level: 11" node_number="69"> genome editing </li> <li class="valid" valid="valid" title="valid: True, node: 70, tag: li, level: 11" node_number="70"> batteries </li> </ul> </div> </div> </div> </div> </header><div class="valid" valid="valid" title="valid: True, node: 71, tag: div, level: 5" node_number="71"><div class="valid" valid="valid" title="valid: True, node: 72, tag: div, level: 6" node_number="72"><div class="valid" valid="valid" title="valid: True, node: 73, tag: div, level: 7" node_number="73"> <div class="valid" valid="valid" title="valid: True, node: 74, tag: div, level: 8" node_number="74"> <div class="valid" valid="valid" title="valid: True, node: 75, tag: div, level: 9" node_number="75"> <ul class="valid" valid="valid" title="valid: True, node: 76, tag: ul, level: 10" node_number="76"> <li class="valid" valid="valid" title="valid: True, node: 77, tag: li, level: 11" node_number="77"> Custom Publishing </li> <li class="valid" valid="valid" title="valid: True, node: 78, tag: li, level: 11" node_number="78"> Advertising Kits </li> <li class="valid" valid="valid" title="valid: True, node: 79, tag: li, level: 11" node_number="79"> Custom Publishing Info </li> <li class="valid" valid="valid" title="valid: True, node: 80, tag: li, level: 11" node_number="80"> Webinars </li> </ul> </div> </div> GET OUR E-ALERTS </div></div></div> <main class="valid" valid="valid" title="valid: True, node: 81, tag: main, level: 5" node_number="81"> <section class="valid" valid="valid" title="valid: True, node: 82, tag: section, level: 6" node_number="82"> <div class="valid" valid="valid" title="valid: True, node: 83, tag: div, level: 7" node_number="83"> <div class="valid" valid="valid" title="valid: True, node: 84, tag: div, level: 8" node_number="84"> <div class="valid" valid="valid" title="valid: True, node: 85, tag: div, level: 9" node_number="85"> <div class="valid" valid="valid" title="valid: True, node: 86, tag: div, level: 10" node_number="86">  <div class="valid" valid="valid" title="valid: True, node: 87, tag: div, level: 11" node_number="87"> <ul class="valid" valid="valid" title="valid: True, node: 88, tag: ul, level: 12" node_number="88"> <li class="valid" valid="valid" title="valid: True, node: 89, tag: li, level: 13" node_number="89">webinar</li><li class="valid" valid="valid" title="valid: True, node: 90, tag: li, level: 13" node_number="90">Technology</li><li class="valid" valid="valid" title="valid: True, node: 91, tag: li, level: 13" node_number="91">Sponsored by MilliporeSigma </li> </ul> <div class="valid" valid="valid" title="valid: True, node: 92, tag: div, level: 12" node_number="92"><h1 class="valid" valid="valid" title="valid: True, node: 93, tag: h1, level: 13" node_number="93">Opportunities and challenges of blood-based biomarkers in Alzheimer's disease</h1></div> <ul class="valid" valid="valid" title="valid: True, node: 94, tag: ul, level: 12" node_number="94"><li class="valid" valid="valid" title="valid: True, node: 95, tag: li, level: 13" node_number="95">15 Dec 2021</li><li class="valid" valid="valid" title="valid: True, node: 96, tag: li, level: 13" node_number="96">12:00 PM ET</li><li class="valid" valid="valid" title="valid: True, node: 97, tag: li, level: 13" node_number="97">Speakers:Lei Liu, M.D., Ph.D,Anitaben Tailor, Ph.D.</li><li class="valid" valid="valid" title="valid: True, node: 98, tag: li, level: 13" node_number="98">Moderator:Jackie Oberst, Ph.D.</li> </ul> </div> </div> </div> </div> </div> </section> <div class="valid" valid="valid" title="valid: True, node: 99, tag: div, level: 6" node_number="99"> <div class="valid" valid="valid" title="valid: True, node: 100, tag: div, level: 7" node_number="100"> <div class="valid" valid="valid" title="valid: True, node: 101, tag: div, level: 8" node_number="101"> <div class="valid" valid="valid" title="valid: True, node: 102, tag: div, level: 9" node_number="102"> <div class="valid" valid="valid" title="valid: True, node: 103, tag: div, level: 10" node_number="103"> <article class="valid" valid="valid" title="valid: True, node: 104, tag: article, level: 11" node_number="104"> <section class="valid" valid="valid" title="valid: True, node: 105, tag: section, level: 12" node_number="105"> <div class="valid" valid="valid" title="valid: True, node: 106, tag: div, level: 13" node_number="106"> <div class="valid" valid="valid" title="valid: True, node: 107, tag: div, level: 14" node_number="107"> <div title="valid: False, node: 108, tag: div, level: 15" node_number="108"> <div title="valid: False, node: 109, tag: div, level: 16" node_number="109"> <time title="valid: False, node: 110, tag: time, level: 17" node_number="110"> <div title="valid: False, node: 111, tag: div, level: 18" node_number="111">15</div> <div title="valid: False, node: 112, tag: div, level: 18" node_number="112"> <div title="valid: False, node: 113, tag: div, level: 19" node_number="113">Dec</div> <div title="valid: False, node: 114, tag: div, level: 19" node_number="114">2021</div> </div> </time> <time title="valid: False, node: 115, tag: time, level: 17" node_number="115"> <div title="valid: False, node: 116, tag: div, level: 18" node_number="116">12:00</div> <div title="valid: False, node: 117, tag: div, level: 18" node_number="117"> <div title="valid: False, node: 118, tag: div, level: 19" node_number="118">PM</div> <div title="valid: False, node: 119, tag: div, level: 19" node_number="119">ET</div> </div> </time> <div title="valid: False, node: 120, tag: div, level: 17" node_number="120"> Register NOWRemaining time: </div> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 121, tag: div, level: 13" node_number="121"> <div class="valid" valid="valid" title="valid: True, node: 122, tag: div, level: 14" node_number="122">Lei Liu, M.D., Ph.DSpeaker</div> <div class="valid" valid="valid" title="valid: True, node: 123, tag: div, level: 14" node_number="123">Anitaben Tailor, Ph.D.Speaker</div> <div class="valid" valid="valid" title="valid: True, node: 124, tag: div, level: 14" node_number="124">Jackie Oberst, Ph.D.Moderator</div> </div> <div class="valid" valid="valid" title="valid: True, node: 125, tag: div, level: 13" node_number="125"> <div class="valid" valid="valid" title="valid: True, node: 126, tag: div, level: 14" node_number="126"> <div title="valid: False, node: 127, tag: div, level: 15" node_number="127"> <span title="valid: False, node: 128, tag: span, level: 16" node_number="128">This webinar is brought to you by the <a title="valid: False, node: 129, tag: a, level: 17" node_number="129"><cite title="valid: False, node: 130, tag: cite, level: 18" node_number="130">Science</cite>/AAAS Custom Publishing Office</a>.</span> </div> </div> <p class="valid" valid="valid" title="valid: True, node: 131, tag: p, level: 14" node_number="131">Identifying more sensitive biomarker tests for Alzheimer&#8217;s disease (AD) is an unmet medical need. It is key in the global efforts to validate disease-modifying AD therapeutics and identify appropriate recipients in clinical trials once more therapies are approved. Fluid biomarkers, especially plasma-based biomarkers, become the most attractive ones as they are non-invasive, relatively economical, and easy to obtain. Emerging blood biomarkers, including amyloid &#946; monomers, oligomers, tau/p-tau, neurofilament light chain, and inflammatory factors, are gathering tremendous research interest. However, there are also challenges in developing blood biomarkers for neurological disease with specificity, precision, and reproducibility. First, biologically, there could be a tiny amount of proteins of the central nervous system entering into the peripheral bloodstream. Second, biochemically, the enriched and complex matrix of human blood strongly interferes with the detection system we use for protein identification and quantification. Third, technically, it is critical to establish a system with high reliability that is also capable of high throughput. Our expert speakers will discuss strategies in developing an ultrasensitive immunoassay* to precisely measure oligomeric amyloid &#946; in human plasma.During the webinar, the viewers will:</p> <ul class="valid" valid="valid" title="valid: True, node: 132, tag: ul, level: 14" node_number="132"> <ul title="valid: False, node: 133, tag: ul, level: 15" node_number="133"> <li title="valid: False, node: 134, tag: li, level: 16" node_number="134">Obtain insights into blood-based biomarkers used in neurological diseases such as Alzheimer&#8217;s disease</li> <li title="valid: False, node: 135, tag: li, level: 16" node_number="135">Discover the challenges and opportunities behind creating blood-based biomarker immunoassays</li> <li title="valid: False, node: 136, tag: li, level: 16" node_number="136">Be able to ask questions during the live broadcast.</li> </ul> </ul> <p class="valid" valid="valid" title="valid: True, node: 137, tag: p, level: 14" node_number="137">This webinar will last for approximately 60 minutes.</p> <p class="valid" valid="valid" title="valid: True, node: 138, tag: p, level: 14" node_number="138">*For Research Use Only. Not For Use In Diagnostic Procedures.</p> </div> </section> </article> </div> <div class="valid" valid="valid" title="valid: True, node: 139, tag: div, level: 10" node_number="139"> <div class="valid" valid="valid" title="valid: True, node: 140, tag: div, level: 11" node_number="140"> <h2 class="valid" valid="valid" title="valid: True, node: 141, tag: h2, level: 12" node_number="141">SPEAKER BIOS</h2> <div class="valid" valid="valid" title="valid: True, node: 142, tag: div, level: 12" node_number="142"> <div class="valid" valid="valid" title="valid: True, node: 143, tag: div, level: 13" node_number="143"> <div class="valid" valid="valid" title="valid: True, node: 144, tag: div, level: 14" node_number="144"> <h4 title="valid: False, node: 145, tag: h4, level: 15" node_number="145">Lei Liu, M.D., Ph.D</h4> </div> <div class="valid" valid="valid" title="valid: True, node: 146, tag: div, level: 14" node_number="146"> <div title="valid: False, node: 147, tag: div, level: 15" node_number="147"> <p title="valid: False, node: 148, tag: p, level: 16" node_number="148">Harvard Medical SchoolBoston, MA</p> </div> <p title="valid: False, node: 149, tag: p, level: 15" node_number="149">Lei Liu, M.D., Ph.D., studied the neurochemistry of Alzheimer&#8217;s disease (AD) at the Shiga University of Medical Science (Otsu, Japan) and completed his Ph.D. thesis in the lab of Dr. Masaki Nishimura. During his graduate research, which involved the characterization of a novel endogenous regulator of the AD-relevant &#947;-secretase complex, Lei was awarded the best basic research of the year in 2014 by the Japan Society for Dementia Research and the Takeda Medical Research Award in 2015 for his work on &#947;-secretase. Following his research interest in dementia, he joined the lab of Dr. Dennis Selkoe at Harvard Medical School/Brigham and Women&#8217;s Hospital in late 2016, where he currently works as an Assistant Professor of Neurology at Harvard Medical School. He has published many significant peer-reviewed research articles on the enzymology involved in AD pathogenesis in prestigious journals, such as Journal of Cell Biology, Nature Communications, Alzheimer&#8217;s Dementia, Neuron, and Journal of Biological Chemistry.</p> <p title="valid: False, node: 150, tag: p, level: 15" node_number="150">In addition to basic molecular biology research, he is also an expert in antibody biology and immunoassay development. His ongoing work on plasma biomarkers in AD is built on multiple ultrasensitive and unique assays to detect up to fg/mL AD-relevant proteins in as little as 10 &#181;L of human plasma. His recent development, an immunoassay to sensitively and specifically quantify the oligomeric state of amyloid-&#946; (oA&#946;), is the first method that has been thoroughly validated for human plasma to monitor A&#946; dynamics in the peripheral blood. This could serve as a critical tool to monitor AD stages and therapeutic interventions. His research goal is to bridge basic research to clinical applications and bring real-life impacts on patient treatments and quality of life.</p> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 151, tag: div, level: 12" node_number="151"> <div class="valid" valid="valid" title="valid: True, node: 152, tag: div, level: 13" node_number="152"> <div class="valid" valid="valid" title="valid: True, node: 153, tag: div, level: 14" node_number="153"> <h4 title="valid: False, node: 154, tag: h4, level: 15" node_number="154">Anitaben Tailor, Ph.D.</h4> </div> <div class="valid" valid="valid" title="valid: True, node: 155, tag: div, level: 14" node_number="155"> <div title="valid: False, node: 156, tag: div, level: 15" node_number="156"> <p title="valid: False, node: 157, tag: p, level: 16" node_number="157">MilliporeSigmaBurlington, MA</p> </div> <p title="valid: False, node: 158, tag: p, level: 15" node_number="158">Dr. Tailor has over 10 years of immunoassay platform experience in the biopharmaceutical industry. Anita earned her Master&#8217;s in Pharmacology at Kings College, London, and then went on to do her Ph.D. in Biochemical Immunopharmacology at the University of London, UK. She was a postdoctoral fellow in physiology and pharmacology at LSU Health Sciences, followed by faculty positions at Johns Hopkins and the U.S. National Institutes of Health. In 2009, Anita moved into industry as a Field Application Scientist for Meso Scale Diagnostics and Singulex (MilliporeSigma). Then in 2016, Anita was appointed the global role of SMC&#8482; Technology and Application Lead within the Life Science Division at MilliporeSigma, where she led multiple teams globally on the utility of SMC&#8482; technology as a bioanalytical tool for multiple research applications within industry and academia. More recently, Anita joined the global Biology Technical Marketing group, focusing on the immunoassay portfolio within pharma and contract research organizations.</p> </div> </div> </div> <h2 class="valid" valid="valid" title="valid: True, node: 159, tag: h2, level: 12" node_number="159">MODERATOR BIO</h2> <div class="valid" valid="valid" title="valid: True, node: 160, tag: div, level: 12" node_number="160"> <div class="valid" valid="valid" title="valid: True, node: 161, tag: div, level: 13" node_number="161"> <div class="valid" valid="valid" title="valid: True, node: 162, tag: div, level: 14" node_number="162"> <h4 title="valid: False, node: 163, tag: h4, level: 15" node_number="163">Jackie Oberst, Ph.D.</h4> </div> <div class="valid" valid="valid" title="valid: True, node: 164, tag: div, level: 14" node_number="164"> <div title="valid: False, node: 165, tag: div, level: 15" node_number="165"> <p title="valid: False, node: 166, tag: p, level: 16" node_number="166">Science/AAASWashington, DC</p> </div> <p title="valid: False, node: 167, tag: p, level: 15" node_number="167">Dr. Oberst did her undergraduate training at the University of Maryland, College Park, and her Ph.D. in Tumor Biology at Georgetown University, Washington D.C. She combined her interests in science and writing by pursuing an M.A. in Journalism from the Philip Merrill College of Journalism at the University of Maryland, College Park. Dr. Oberst joined Science/AAAS in 2016 as the Assistant Editor for Custom Publishing. Before then she worked at Nature magazine, the Howard Hughes Medical Institute, The Endocrine Society, and the National Institutes of Mental Health.</p> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 168, tag: div, level: 11" node_number="168"> <h5 class="valid" valid="valid" title="valid: True, node: 169, tag: h5, level: 12" node_number="169">Sponsored By:</h5> </div> </div> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 170, tag: div, level: 6" node_number="170"> <div class="valid" valid="valid" title="valid: True, node: 171, tag: div, level: 7" node_number="171"> <div class="valid" valid="valid" title="valid: True, node: 172, tag: div, level: 8" node_number="172"> <div class="valid" valid="valid" title="valid: True, node: 173, tag: div, level: 9" node_number="173"> <div class="valid" valid="valid" title="valid: True, node: 174, tag: div, level: 10" node_number="174"> <h2 class="valid" valid="valid" title="valid: True, node: 175, tag: h2, level: 11" node_number="175">Webinars</h2> <div class="valid" valid="valid" title="valid: True, node: 176, tag: div, level: 11" node_number="176"><div class="valid" valid="valid" title="valid: True, node: 177, tag: div, level: 12" node_number="177"><div class="valid" valid="valid" title="valid: True, node: 178, tag: div, level: 13" node_number="178"> <article class="valid" valid="valid" title="valid: True, node: 179, tag: article, level: 14" node_number="179"> <div title="valid: False, node: 180, tag: div, level: 15" node_number="180"> <div title="valid: False, node: 181, tag: div, level: 16" node_number="181"> <div title="valid: False, node: 182, tag: div, level: 17" node_number="182"> <div title="valid: False, node: 183, tag: div, level: 18" node_number="183">Technology<time title="valid: False, node: 184, tag: time, level: 19" node_number="184">15 Dec 2021</time> Sponsored by MilliporeSigma </div> <div title="valid: False, node: 185, tag: div, level: 18" node_number="185"> <h3 title="valid: False, node: 186, tag: h3, level: 19" node_number="186">Opportunities and challenges of blood-based biomarkers in Alzheimer's disease</h3> </div> <div title="valid: False, node: 187, tag: div, level: 18" node_number="187"><p title="valid: False, node: 188, tag: p, level: 19" node_number="188">Identifying more sensitive biomarker tests for Alzheimer&#8217;s disease (AD) is an unmet medical need. It is key in the global efforts to validate disease-modifying AD therapeutics and identify appropriate recipients in clinical trials once more therapies are approved. Fluid biomarkers, especially plasma-based biomarkers, become the most attractive ones as they are non-invasive, relatively economical, and easy to obtain. Emerging blood biomarkers, including amyloid &#946; monomers, oligomers, tau/p-tau, neurofilament light chain, and inflammatory factors, are gathering tremendous research interest. However, there are also challenges in developing blood biomarkers for neurological disease with specificity, precision, and reproducibility. First, biologically, there could be a tiny amount of proteins of the central nervous system entering into the peripheral bloodstream. Second, biochemically, the enriched and complex matrix of human blood strongly interferes with the detection system we use for protein identification and quantification. Third, technically, it is critical to establish a system with high reliability that is also capable of high throughput. Our expert speakers will discuss strategies in developing an ultrasensitive immunoassay* to precisely measure oligomeric amyloid &#946; in human plasma.During the webinar, the viewers will:</p> <ul title="valid: False, node: 189, tag: ul, level: 19" node_number="189"> <ul title="valid: False, node: 190, tag: ul, level: 20" node_number="190"> <li title="valid: False, node: 191, tag: li, level: 21" node_number="191">Obtain insights into blood-based biomarkers used in neurological diseases such as Alzheimer&#8217;s disease</li> <li title="valid: False, node: 192, tag: li, level: 21" node_number="192">Discover the challenges and opportunities behind creating blood-based biomarker immunoassays</li> <li title="valid: False, node: 193, tag: li, level: 21" node_number="193">Be able to ask questions during the live broadcast.</li> </ul> </ul> <p title="valid: False, node: 194, tag: p, level: 19" node_number="194">This webinar will last for approximately 60 minutes.</p> <p title="valid: False, node: 195, tag: p, level: 19" node_number="195">*For Research Use Only. Not For Use In Diagnostic Procedures.</p></div> </div> <div title="valid: False, node: 196, tag: div, level: 17" node_number="196"> <div title="valid: False, node: 197, tag: div, level: 18" node_number="197"> <div title="valid: False, node: 198, tag: div, level: 19" node_number="198">15</div> <div title="valid: False, node: 199, tag: div, level: 19" node_number="199"> <div title="valid: False, node: 200, tag: div, level: 20" node_number="200">Dec</div> <div title="valid: False, node: 201, tag: div, level: 20" node_number="201">2021</div> </div> </div> Register Now </div> </div> </div> </article> </div><div class="valid" valid="valid" title="valid: True, node: 202, tag: div, level: 13" node_number="202"> <article class="valid" valid="valid" title="valid: True, node: 203, tag: article, level: 14" node_number="203"> <div title="valid: False, node: 204, tag: div, level: 15" node_number="204"> <div title="valid: False, node: 205, tag: div, level: 16" node_number="205"> <div title="valid: False, node: 206, tag: div, level: 17" node_number="206"> <div title="valid: False, node: 207, tag: div, level: 18" node_number="207">Technology<time title="valid: False, node: 208, tag: time, level: 19" node_number="208">8 Dec 2021</time> Sponsored by Tecan </div> <div title="valid: False, node: 209, tag: div, level: 18" node_number="209"> <h3 title="valid: False, node: 210, tag: h3, level: 19" node_number="210">Enabling the transition between research and clinical medicine in oncology</h3> </div> <div title="valid: False, node: 211, tag: div, level: 18" node_number="211"><p title="valid: False, node: 212, tag: p, level: 19" node_number="212">The translation of bench research into the clinical environment has accelerated significantly in recent years, and the need for clinically validated workflows has never been stronger. This webinar takes a closer look at this need, particularly in the oncology space, and discusses what the future for workflow validation might be. The considerable knowledge built up over years&#8212;and especially during the recent COVID-19 pandemic&#8212;is relevant to many disease states and can be applied universally, ensuring that globally standardized, scalable technologies can realize their full clinical potential.The discussion will include:</p> <ul title="valid: False, node: 213, tag: ul, level: 19" node_number="213"> <li title="valid: False, node: 214, tag: li, level: 20" node_number="214">The latest developments in integrated diagnostics and patient profiling, combining molecular and proteomics workflows</li> <li title="valid: False, node: 215, tag: li, level: 20" node_number="215">The urgent need for translational research of biomarkers that have clinical relevance for optimizing diagnosis and treatment plans</li> <li title="valid: False, node: 216, tag: li, level: 20" node_number="216">The challenges of translating new techniques&#8212;such as liquid biopsies&#8212;into regulated, scalable methodologies that will drive future global diagnostics and therapeutics</li> <li title="valid: False, node: 217, tag: li, level: 20" node_number="217">The importance of building firm foundations in robust and reproducible research technologies, democratization of automated workflows, and digital connectivity of data. </li> </ul> <p title="valid: False, node: 218, tag: p, level: 19" node_number="218">This webinar will last for approximately 60 minutes.</p></div> </div> </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 219, tag: article, level: 14" node_number="219"> <div title="valid: False, node: 220, tag: div, level: 15" node_number="220"> <div title="valid: False, node: 221, tag: div, level: 16" node_number="221"> <div title="valid: False, node: 222, tag: div, level: 17" node_number="222"> <div title="valid: False, node: 223, tag: div, level: 18" node_number="223">Technology<time title="valid: False, node: 224, tag: time, level: 19" node_number="224">30 Nov 2021</time> Sponsored by Illumina </div> <div title="valid: False, node: 225, tag: div, level: 18" node_number="225"> <h3 title="valid: False, node: 226, tag: h3, level: 19" node_number="226">Redefining NGS in Cancer Research</h3> </div> <div title="valid: False, node: 227, tag: div, level: 18" node_number="227"><p title="valid: False, node: 228, tag: p, level: 19" node_number="228">Cancer research using next-generation sequencing (NGS) has ushered in numerous advancements in diagnosis and treatment. In addition to identifying individual targetable alterations, sequencing methods can now reveal tumor mutational load and tumor-specific antigens that might predict a therapeutic response to targeted therapies, immune-checkpoint inhibitors, and personalized anticancer vaccines. Emerging clinical applications of cancer genomics include monitoring treatment responses and characterizing mechanisms of resistance. Genomic assays that enable characterization of somatic and germline defects in individual tumor samples are increasingly being used in clinical diagnostics as a means of identifying therapeutic options. Additionally, the occurrence of shared targetable alterations across diverse tumor types has prompted new paradigms in the application of genomic profiling and the design of clinical trials.Although often perceived as a primarily genomic and/or transcriptomic analysis approach, NGS has evolved beyond the genome and transcriptome. It can now be used to characterize the proteome, epigenome, noncoding RNAs, and even small RNAs. Furthermore, cellular characterization can occur at multiple levels of resolution. If someone is seeking to characterize average state of many cells, bulk sequencing is still a fantastic, straightforward application. However, it&#8217;s also now possible to embrace the inherent heterogeneity of a tissue by performing single-cell sequencing and understanding individual cells (but without spatial context). These applications further enrich cancer research and drive future breakthroughs.During this webinar, our expert speakers will:</p> <ul title="valid: False, node: 229, tag: ul, level: 19" node_number="229"> <li title="valid: False, node: 230, tag: li, level: 20" node_number="230">Provide background information on NGS</li> <li title="valid: False, node: 231, tag: li, level: 20" node_number="231">Discuss the achievements and challenges associated with NGS</li> <li title="valid: False, node: 232, tag: li, level: 20" node_number="232">Discuss how an integrated multiomics approach can be used in cancer diagnosis and treatment</li> <li title="valid: False, node: 233, tag: li, level: 20" node_number="233"><span title="valid: False, node: 234, tag: span, level: 21" node_number="234">Answer your questions during the live broadcast.</span></li> </ul></div> </div> </div> </div> </article> </div></div></div> </div> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 235, tag: div, level: 6" node_number="235"> <renderdropzone class="valid" valid="valid" title="valid: True, node: 236, tag: renderdropzone, level: 7" node_number="236"/> </div> </main> </div> </div> </div> </body>
        <style tyle='text/css'>
body{
    position: relative;
    padding-left: 30px;
    top: 60px;
}
* {
    border: 1px solid #eee;
    padding: 5px 12px;
    margin: 3px 0;
    box-sizing: content-box;
    background-color: #fff;
    cursor: no-drop;
}
main:hover > *, section:hover > *, header:hover > *, nav:hover > *, a:hover > *, div:hover > *, p:hover > *, ul:hover > *, h1:hover > *, h2:hover > *, h3:hover > *, li:hover > *, span:hover > *{
    border: 2px solid green;
    background-color: #fffeee;
    padding: 5px 23px !important;
    margin: 1px 0;
    color: green;
}
main:hover, section:hover, header:hover, nav:hover, a:hover, div:hover, p:hover, ul:hover, h1:hover, h2:hover, h3:hover, li:hover, span:hover{
    border: 1px solid #fff;
    background-color: #eee;
}
a, span {
    display: block;
}
.selected {
    border: 2px solid orchid !important;
    opacity: 0.8;
    color: orchid !important;
}
.selected * {
    padding: 2px !important;
    color: orchid !important;
}
.valid {
  cursor: pointer;
}
.btn{
  cursor: pointer;
  font-weight: bolder;
  padding: 8px;
}
</style> 
        <script>function OpenOriginalLink($event){
    $event.stopPropagation();
    console.log(url);
}

function removeItem($event){
    $event.stopPropagation();
    console.log('Remove item: ', url)
    localStorage.removeItem(url)
}

function exportData($event){
    $event.stopPropagation();

    result = []
    for(let i=0; i<localStorage.length; i++) {
        let key = localStorage.key(i);
        result.push(localStorage.getItem(key))
    }
    const _url = URL.createObjectURL(new Blob([result.join("\n")], {type: 'text/plain'}))
    $event.target.href = _url;
    localStorage.clear()
}

var removeItemBtn = document.createElement("BUTTON");   // Create a <button> element
removeItemBtn.innerHTML = "Remove Item";
removeItemBtn.classList.add('btn');
removeItemBtn.style.position = "fixed";
removeItemBtn.style.left = '5px';
removeItemBtn.style.top = 0;
removeItemBtn.style.border = "1px solid";
removeItemBtn.style.boxShadow = "3px 3px #888";
removeItemBtn.onclick = removeItem;
document.body.appendChild(removeItemBtn);

var goToOriginLink = document.createElement("A");   // Create a <button> element
goToOriginLink.innerHTML = "GoToOrigin";
goToOriginLink.classList.add('btn');
goToOriginLink.style.position = "fixed"
goToOriginLink.style.left = '115px'
goToOriginLink.style.top = 0;
goToOriginLink.onclick = OpenOriginalLink;
goToOriginLink.setAttribute('href', decodeURIComponent(url));
goToOriginLink.target = '_blank';
document.body.appendChild(goToOriginLink);

var current = new Date
var exportDataLink = document.createElement("A");   // Create a <button> element
exportDataLink.innerHTML = "Export data";
exportDataLink.classList.add('btn');
exportDataLink.download = current.toISOString() + '.exported.txt';
exportDataLink.style.position = "fixed";
exportDataLink.style.right = '5px';
exportDataLink.style.top = 0;
exportDataLink.style.border = "1px solid #888";
exportDataLink.style.boxShadow = "3px 3px #888";
exportDataLink.onclick = exportData;
document.body.appendChild(exportDataLink);

data = {
    'title': null ,
    'article': null
}

var body = document.getElementsByTagName("body")[0];

body.onclick = function($e){
    var num = $e.target.getAttribute('node_number')
    var valid = $e.target.getAttribute('valid')

    if(!valid){
        console.log("Element is invalid")
        return
    }

    if(data.length > 2){
        data = data.splice(0, 2)
    }

    console.log("node:", $e.target)

    if(!data.title && !data.article){
        data.title = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else if (data.title && !data.article){
        data.article = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else{
        selected = Array.from(document.getElementsByClassName("selected"))
        selected.forEach(function(el){
            el.classList.remove('selected')
        })

        data.title = num;
        data.article = null;
        $e.target.classList.add('selected')

    }

    if(data.title && data.article){
        var obj = {
            url: url,
            text: body_html,
            title: data.title,
            article: data.article,
        }

        var datasetItem = JSON.stringify(obj)
        localStorage.setItem(url, datasetItem)
    }
}
</script> 
      </html>